Tarsus Pharmaceuticals, Inc.
TARS • NASDAQ • Stock Fundamentals
Tarsus Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bobak R. Azamian, with a market cap of $2.7B.
Market Cap$2.7B
Employees244.0
CEOBobak R. Azamian
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Tarsus Pharmaceuticals, Inc. FAQ
Common questions about Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. (TARS) has a market capitalization of $2.7B and trades on NASDAQ.
Tarsus Pharmaceuticals, Inc. has approximately 244 employees.